Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
94.06
+1.58 (1.71%)
At close: Apr 28, 2026, 4:00 PM EDT
94.00
-0.06 (-0.06%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Mirum Pharmaceuticals stock have an average target of 119, with a low estimate of 77 and a high estimate of 150. The average target predicts an increase of 26.51% from the current stock price of 94.06.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 | 4 | 4 |
| Buy | 6 | 6 | 6 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $95 → $112 | Buy | Maintains | $95 → $112 | +19.07% | Apr 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $130 → $150 | Strong Buy | Maintains | $130 → $150 | +59.47% | Apr 27, 2026 |
| Citizens | Citizens | Buy Reiterates $132 | Buy | Reiterates | $132 | +40.34% | Apr 21, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $117 → $125 | Strong Buy | Maintains | $117 → $125 | +32.89% | Mar 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $130 | Strong Buy | Reiterates | $130 | +38.21% | Mar 23, 2026 |
Financial Forecast
Revenue This Year
658.00M
from 521.31M
Increased by 26.22%
Revenue Next Year
803.00M
from 658.00M
Increased by 22.04%
EPS This Year
-1.90
from -0.47
EPS Next Year
0.01
from -1.90
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 690.5M | 883.9M | ||||||
| Avg | 658.0M | 803.0M | ||||||
| Low | 617.4M | 695.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 32.5% | 34.3% | ||||||
| Avg | 26.2% | 22.0% | ||||||
| Low | 18.4% | 5.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.43 | 2.10 | ||||||
| Avg | -1.90 | 0.01 | ||||||
| Low | -2.76 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.